<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02866526</url>
  </required_header>
  <id_info>
    <org_study_id>2016-30</org_study_id>
    <nct_id>NCT02866526</nct_id>
  </id_info>
  <brief_title>Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia</brief_title>
  <acronym>TRANSHEMO</acronym>
  <official_title>Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe haemophilia is a rare disease characterized by spontaneous bleedings from early
      childhood, which may lead to various complications especially in joints. Due to advances in
      medical care and more specifically in the development of prophylactic strategies by the
      application of clotting factor concentrates, life expectancy of persons with severe
      haemophilia has significantly increased over the last decades. This progress requires a
      long-term follow-up, including into adulthood. The adherence to a regular clinical follow-up
      and to a prophylactic treatment then depends on how successful patients' transition from
      childhood to adulthood has been as this process involves a transfer of responsibility from
      parents to patients concerning the management of their health. Beyond the issue of patients'
      adherence, a suboptimal transition may also impair quality of life and the entry into
      adulthood, especially at the social, emotional and professional levels. Only a few studies
      have been conducted to identify the specific needs and difficulties young persons with severe
      haemophilia experience during their transition from childhood to adulthood, and none of these
      studies has been carried out in France where the features of the health care system are very
      specific.

      Therefore, this study aims to address the issue of transition into adulthood among young
      persons with severe haemophilia in France. This study will focus not only on the facilitators
      and barriers of the access to health care but also, from a more global perspective, on all
      the specific concerns and difficulties they may experience as they grow into adulthood which
      may impair their long-term health related quality of life as well as their personal
      empowerment. This study will also allow to identify some of the socio- cognitive, emotional,
      and familial determinants of a good transition into adulthood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to assess the impact of transition from adolescence into
      adulthood especially on adherence to health care, among young people with severe haemophilia
      in France.

      The operational objectives of this study are: i) to compare the level of adherence in
      adolescents and in young adults (YA) ii) to identify determinants (medical, organisational,
      socio-demographic and social, and psychosocial and behavioural factors) of the level of
      adherence in YPWH (young people with haemophilia), iii) to assess specific factors involved
      in suboptimal level of adherence in the sub-groups of adolescents on one hand and of YA on
      the other hand, iv) to identify groups of patients (clusters) regarding both their level of
      adherence and their psychosocial characteristics, v) to examine trough a qualitative approach
      YPWH needs and expectations towards the health care system during the transition process, and
      to identify some ways to improve their global care.

      This study is an exploratory, observational, multicentric, transversal study aimed at
      describing the perceptions of adolescents (14-17 years old) with severe haemophilia to those
      of young adults (20-29 years old) regarding their expectations and their feelings about
      growing into adulthood. Every patient enrolled in the FranceCoag national cohort (cohort of
      French patients suffering from inherited deficiencies of coagulation proteins), suffering
      from severe haemophilia, aged from 14 to 17 years old or from 20 to 29 years old, will be
      offered to get enrolled in the TRANSHEMO study (expected number eligible of participants: 154
      adolescents and 389 young adults). , among whom 70% are expected to take part in the study).
      The patients' participation in this study will not modify their medical or paramedical care.
      A multifocal approach which combines both quantitative and qualitative data collection will
      be proposed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of follow-up visits / theoretical number of follow-up visits over the last two years</measure>
    <time_frame>Two years</time_frame>
    <description>Adherence to clinical follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of injections of prophylactic treatment realized / theoretical number of injections of prophylactic treatment over the last three months</measure>
    <time_frame>3 months</time_frame>
    <description>Adherence to prophylactic treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient-reported adherence</measure>
    <time_frame>one day</time_frame>
    <description>Specific item of the patient questionnaire (0-10 points)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician-reported adherence of the patient</measure>
    <time_frame>one day</time_frame>
    <description>Specific item of the medical questionnaire (0-10 points)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of haemorrhagic events</measure>
    <time_frame>one day</time_frame>
    <description>Specific item of the medical questionnaire</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Haemophilia</condition>
  <arm_group>
    <arm_group_label>group1</arm_group_label>
    <description>adolescents (14-17 years old)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <description>young adults (20-29 years old)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient questionnaire</intervention_name>
    <description>quantitative and qualitative data collection will be proposed.</description>
    <arm_group_label>group1</arm_group_label>
    <arm_group_label>group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        cohort of persons with severe haemophilia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with severe haemophilia

          -  Patients enrolled in the FranceCoag national cohort

          -  Patients aged from 14 to 17 years old (adolescents group) or from 20 to 29 years old
             (young adults group)

          -  Adults patients having given their agreement to participate in the study, or minor
             patients authorized to participate in the study by their parents or their legal
             representatives

        Exclusion Criteria:

          -  Patients with comprehension problems

          -  Patients unable to read or to write

          -  Adults patients not having given their agreement to participate in the study, or minor
             patients unauthorized to participate in the study by their parents or their legal
             representatives
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>ASSISTANCE Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Noémie RESSEGUIER</last_name>
    <phone>0491324272</phone>
    <phone_ext>+33</phone_ext>
    <email>noemie.resseguier@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU D'Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annelise VOYER</last_name>
    </contact>
    <investigator>
      <last_name>Annelise VOYER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Anne BERTRAND</last_name>
    </contact>
    <investigator>
      <last_name>Marie Anne BERTRAND</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoann HUGUENIN</last_name>
    </contact>
    <investigator>
      <last_name>Yoann HUGUENIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte PAN PETESCH</last_name>
    </contact>
    <investigator>
      <last_name>Brigitte PAN PETESCH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU CAEN</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie BOREL-DERLON</last_name>
    </contact>
    <investigator>
      <last_name>Annie BOREL-DERLON</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Chambery</name>
      <address>
        <city>Chambéry</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie GAY</last_name>
    </contact>
    <investigator>
      <last_name>Valérie GAY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélien LEBRETON</last_name>
    </contact>
    <investigator>
      <last_name>Aurélien LEBRETON</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21034</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabienne VOLOT</last_name>
    </contact>
    <investigator>
      <last_name>Fabienne VOLOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoit POLACK</last_name>
    </contact>
    <investigator>
      <last_name>Benoit POLACK</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Versailles/ Le Chesnay</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78157</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne RAFOWICZ</last_name>
    </contact>
    <investigator>
      <last_name>Anne RAFOWICZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenny GOUDEMAND</last_name>
    </contact>
    <investigator>
      <last_name>Jenny GOUDEMAND</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline OUDOT</last_name>
    </contact>
    <investigator>
      <last_name>Caroline OUDOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civiles de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Lienhart</last_name>
    </contact>
    <investigator>
      <last_name>Anne Lienhart</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine Meunier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille Hôpital de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noémie RESSEGUIER</last_name>
      <phone>0491324272</phone>
      <phone_ext>+33</phone_ext>
      <email>noemie.resseguier@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé CHAMBOST</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Montmorency</name>
      <address>
        <city>Montmorency</city>
        <zip>95160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abel HASSOUN</last_name>
    </contact>
    <investigator>
      <last_name>Abel HASSOUN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine BIRON-Andréani</last_name>
    </contact>
    <investigator>
      <last_name>Christine BIRON-Andréani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte FROTSCHER</last_name>
    </contact>
    <investigator>
      <last_name>Brigitte FROTSCHER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc TROSSAERT</last_name>
    </contact>
    <investigator>
      <last_name>Marc TROSSAERT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice MONPOUX</last_name>
    </contact>
    <investigator>
      <last_name>Fabrice MONPOUX</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Paris</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie HARROCHE</last_name>
    </contact>
    <investigator>
      <last_name>Annie HARROCHE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Paris</name>
      <address>
        <city>Paris</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne RAFOWICZ</last_name>
    </contact>
    <investigator>
      <last_name>Anne RAFOWICZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe NGUYEN</last_name>
    </contact>
    <investigator>
      <last_name>Philippe NGUYEN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>benoit GUILLET</last_name>
    </contact>
    <investigator>
      <last_name>Benoit GUILLET</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie BAYART</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre CHAMOUNI</last_name>
    </contact>
    <investigator>
      <last_name>Pierre CHAMOUNI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Réunion</name>
      <address>
        <city>Saint-Denis</city>
        <zip>97405</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane VANDERBECKEN</last_name>
    </contact>
    <investigator>
      <last_name>Stéphane VANDERBECKEN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire BERGER</last_name>
    </contact>
    <investigator>
      <last_name>Claire BERGER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brigitte TARDY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique DESPREZ</last_name>
    </contact>
    <investigator>
      <last_name>Dominique DESPREZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ségolène CLAEYSSENS-DONADEL</last_name>
    </contact>
    <investigator>
      <last_name>Ségolène CLAEYSSENS-DONADEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves GRUEL</last_name>
    </contact>
    <investigator>
      <last_name>Yves GRUEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>August 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2016</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adolescents</keyword>
  <keyword>young adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

